Last reviewed · How we verify
NCT03250767
Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement
trial testing Integra Titan Modular Shoulder System 2.5 in Osteo Arthritis Shoulders in 58 participants. Terminated before completion.
10 March 2023
Quick facts
| Lead sponsor | Smith & Nephew, Inc. |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 58 |
| Start date | 1 August 2017 |
| Primary completion | 10 March 2023 |
| Estimated completion | 10 March 2023 |
| Sites | 7 locations across United States |
Drugs / interventions tested
- Integra Titan Modular Shoulder System 2.5
Conditions studied
- Osteo Arthritis Shoulders — all drugs for Osteo Arthritis Shoulders →
- Traumatic Arthritis — all drugs for Traumatic Arthritis →
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Sponsor
Smith & Nephew, Inc. — full company profile →
Who can join
18 and older, any sex, with Osteo Arthritis Shoulders or Traumatic Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A post market, prospective, non-randomized, multi-center, open-label, clinical study using survivorship as the reference performance goal to study the safety and efficacy of the Titan Modular Shoulder System 2.5 when used for primary shoulder arthroplasty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03250767
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteo Arthritis Shoulders
Currently open trials in the same condition.
- NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting
- NCT05700682 — Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee · recruiting
- NCT04238143 — Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis · NA · recruiting
- NCT04529798 — Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless · recruiting
- NCT05603728 — Exactech Shoulder Post Market Clinical Follow-up Study · recruiting
Other Smith & Nephew, Inc. trials
Trials by the same sponsor.
- NCT07025304 — Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate · NA · recruiting
- NCT06916728 — A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Ca · enrolling by invitation
- NCT06831448 — Human Participant Study of a Prototype Multilayer Foam Dressing on Intact Skin. · NA · completed
- NCT06700850 — Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin · NA · completed
- NCT06306716 — A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03250767 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Smith & Nephew, Inc.
- Last refreshed: 9 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03250767.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing